WinMEMS Technologies, a joint venture subsidiary with U-GEN Biotechnology Inc., has developed a novel technology platform called EMMB(EdgeCode® Multiplex Magnetic Bead) system for diagnostic applications in the bio-medical industry. This platform is to be used for IVD (In Vitro Diagnostic Device) products or life science researches. With our unique semiconductor process techniques, this powerful platform enables the users to track down multiple-biomarkers simultaneously in a single well of specimen, from a few up to 4,096 or even 1 billion types of biomarkers.  This platform can be used for both molecular assays (nucleic acid molecules for genomic analysis) or immuno assays (antibodies/antigens for proteomic analysis). Our EMMB also shows its superior values on both high sensitivity (LOD ~ 0.01% for molecular assays, or pg/ml level for immune assays) and wide dynamic range (up to 6 magnitudes of order) performances.
With the unique geometrical design, the EMMB has a smaller areal dimension compared to the competitors’ products, which allows the users to populate more beads in a single well and therefore tracks down more biomarkers.  WinMEMS has acquired several patents in many countries, including USA, China, Japan, Korea and Taiwan. 
WinMEMS strives to support our customers to gain the competitive advantages in their product development. WinMEMS welcomes you to be our business partner and we make it easy to turn your precious research results into real products.